Downregulation of EphA7 by hypermethylation in colorectal cancer

Oncogene

Volumn 24, Issue 36, 2005, Pages 5637-5647

  Wang, Jiandong ^a   Kataoka, Hideki ^a   Suzuki, Masaya ^a   Sato, Naomi ^a   Nakamura, Ritsuko ^a   Tao, Hong ^a   Maruyama, Keiji ^a   Isogaki, Jun ^a   Kanaoka, Shigeru ^a   Ihara, Megumi ^a   Tanaka, Masamitsu ^a,c   Kanamori, Masao ^a,b   Nakamura, Toshio ^a   Shinmura, Kazuya ^a   Sugimura, Haruhiko ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Biwako Seikei Sport College   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Colorectal cancer; DNA methylation; EphA7

Indexed keywords

EPHRIN; EPHRIN A7; EPHRIN RECEPTOR A7; UNCLASSIFIED DRUG; MESSENGER RNA;

ADENOCARCINOMA; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; COLON CANCER; COLON CARCINOGENESIS; COLORECTAL ADENOMA; COLORECTAL CANCER; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECTUM CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSLATION; TUMOR DIFFERENTIATION; AGED; CELL LINE; CLASSIFICATION; COLORECTAL TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; SEXUAL DEVELOPMENT;

AGED; CELL LINE; COLORECTAL NEOPLASMS; CPG ISLANDS; DNA METHYLATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; RECEPTOR, EPHA7; RNA, MESSENGER; SEX CHARACTERISTICS;

EID: 24644498612     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1208720     Document Type: Article

References (34)

1. Adams RH. (2002). Semin. Cell Dev. Biol., 13, 55-60.
2. Aoki M, Yamashita T and Tohyama M. (2004). J. Biol. Chem., 279, 32643-32650.
3. Bardelli A, Parsons DW, Silliman N, Ptak J, Szabo S, Saha S, Markowitz S, Willson JK, Parmigiani G, Kinzler KW, Vogelstein B and Velculescu VE. (2003). Science, 300, 949.
4. Brock MV, Gou M, Akiyama Y, Muller A, Wu TT, Montgomery E, Deasel M, Germonpre P, Rubinson L, Heitmiller RF, Yang SC, Forastiere AA, Baylin SB and Herman JG. (2003). Clin. Cancer Res., 9, 2912-2919.
5. Chin-Sang ID, George SE, Ding M, Moseley SL, Lynch AS and Chisholm AD. (1999). Cell, 99, 781-790.
6. Chin-Sang ID, Moseley SL, Ding M, Harrington RJ, George SE and Chisholm AD. (2002). Development, 129, 5499-5510.
7. Ciossek T, Millauer B and Ullrich A. (1995). Oncogene, 10, 97-108.
8. Clark SJ, Harrison J, Paul CL and Frommer M. (1994). Nucleic Acids Res., 22, 2990-2997.
9. Cunningham JM, Christensen ER, Tester DJ, Kim CY, Roche PC, Burgart LJ and Thibodeau SN. (1998). Cancer Res., 58, 3455-3460.
10. Dottori M, Down M, Huttmann A, Fitzpatrick DR and Boyd AW. (1999). Blood, 94, 2477-2486.
11. Easty DJ, Hill SP, Hsu MY, Fallowfield ME, Florence VA, Herlyn M and Bennett DC. (1999). Int. J. Cancer, 84, 494-501.
12. Endo Y, Sugimura H and Kino I. (1995). Pathol. Int., 45, 602-604.
13. Favre CJ, Mancuso M, Maas K, McLean JW, Baluk P and McDonald DM. (2003). Am. J. Physiol. Heart Circ. Physiol, 285, H1917-H1938.
14. Fox BP and Kandpal RP. (2004). Biochem. Biophys. Res. Commun., 318, 882-892.
15. Friedman GC and O'Leary DD. (1996). Curr. Opin. Neurobiol., 6, 127-133.
16. Frisen J, Holmberg J and Barbacid M. (1999). EMBO J., 18, 5159-5165.
17. Goel A, Arnold CN, Niedzwiecki D, Carethers JM, Dowell JM, Wasserman L, Compton C, Mayer RJ, Bertagnolli MM and Boland CR. (2004). Cancer Res., 64, 3014-3021.
18. Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB. (1996). Proc. Natl. Acad. Sci. USA, 93, 9821-9826.
19. Hirai H, Maru Y, Hagiwara K, Nishida J and Takaku F. (1987). Science, 238, 1717-1720.
20. Hsieh CJ, Klump B, Holzmann K, Borchard F, Gregor M and Porschen R. (1998). Cancer Res., 58, 3942-3945.
21. Kataoka H, Igarashi H, Kanamori M, Ihara M, Wang JD, Wang YJ, Li ZY, Shimamura T, Kobayashi T, Maruyama K, Nakamura T, Arai H, Kajimura M, Hanai H, Tanaka M and Sugimura H. (2004). Cancer Sci., 95, 136-141.
22. Kataoka H, Tanaka M, Kanamori M, Yoshii S, Ihara M, Wang YJ, Song JP, Li ZY, Arai H, Otsuki Y, Kobayashi T, Konno H, Hanai H and Sugimura H. (2002). J. Cancer Res. Clin. Oncol., 128, 343-348.
23. Kiyokawa E, Takai S, Tanaka M, Iwase T, Suzuki M, Xiang YY, Naito Y, Yamada K, Sugimura H and Kino I. (1994). Cancer Res., 54, 3645-3650.
24. Liu W, Ahmad SA, Jung YD, Reinmuth N, Fan F, Bucana CD and Ellis LM. (2002). Cancer, 94, 934-939.
25. Liu W, Jung YD, Ahmad SA, McCarty MF, Stoeltzing O, Reinmuth N, Fan F and Ellis LM. (2004). Br. J. Cancer, 90, 1620-1626.
26. Miyazaki T, Kato H, Fukuchi M, Nakajima M and Kuwano H. (2003). Int. J. Cancer, 103, 657-663.
27. Shen L, Kondo Y, Hamilton SR, Rashid A and Issa JP. (2003). Gastroenterology, 124, 626-633.
28. Stephenson SA, Slomka S, Douglas EL, Hewett PJ and Hardingham JE. (2001). BMC Mol. Biol., 2, 15.
29. Sullivan DC and Bicknell R. (2003). Br. J. Cancer, 89, 228-231.
30. Tang XX, Brodeur GM, Campling BG and Ikegaki N. (1999). Clin. Cancer Res., 5, 455-460.
31. Tao H, Shinmura K, Hanaoka T, Natsukawa S, Shaura K, Koizumi Y, Kasuga Y, Ozawa T, Tsujinaka T, Li Z, Yamaguchi S, Yokota J, Sugimura H and Tsugane S. (2004). Carcinogenesis, 25, 1859-1866.
32. Valenzuela DM, Rojas E, Griffiths JA, Compton DL, Gisser M, Ip NY, Goldfarb M and Yancopoulos GD. (1995). Oncogene, 10, 1573-1580.
33. Wiencke JK, Zheng S, Lafuente A, Lafuente MJ, Grudzen C, Wrensch MR, Miike R, Ballesta A and Trias M. (1999). Cancer Epidemiol. Biomarkers Prev., 8, 501-506.
34. Wu Q, Suo Z, Risberg B, Karlsson MG, Villman K and Nesland JM. (2004). Pathol. Oncol. Res., 10, 26-33.